Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

NCT01156012 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: T2345
DRUG: Prostaglandin

Sponsor

Laboratoires Thea